Skip to main content

Advertisement

Log in

Effect of Aryl-Cyclohexanones and their Derivatives on Macrophage Polarization In Vitro

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Macrophages are critical in both tissue homeostasis and inflammation, and shifts in their polarization have been indicated as pivotal for the resolution of inflammatory processes. Inflammation is a complex and necessary component of the immune response to stimuli that are harmful to host homeostasis and is regulated by cellular and molecular events that remain a source of ongoing investigation. Among the compounds studied that have potential against autoimmune and inflammatory diseases, cannabinoids are currently highlighted. In this work, nineteen aryl-cyclohexanones diesters and their derivatives were synthesized based on the aryl-cyclohexane skeleton of phytocannabinoids, such as cannabidiol (CBD), and were evaluated for their anti-inflammatory and macrophage polarization potential. The results showed that Compound 4 inhibited the production of nitric oxide in RAW 264.7 macrophages. Furthermore, it reduced the levels of pro-inflammatory cytokines IL-12p70, TNF-α, IFN-γ, MCP-1, and IL-6 while, at the same time, was able to increase the production of anti-inflammatory cytokines IL-4, IL-10, and IL-13. Compound 4 also reduced macrophage apoptosis, increased the expression of the CD206 (mannose receptor) and at the same time, decreased the expression of CD284 (TLR-4 receptor) on the surface of these cells. Finally, it increased the phagocytic capacity and inhibited the phosphorylation of the p65 of NF-kβ. In conclusion, Compound 4, identified as diethyl-4-hydroxy-2-(4-methoxyphenyl)-4-methyl-6-oxocyclohexane-1–3-dicarboxylate, showed significant anti-inflammatory effect, while demonstrating the ability to transform phenotypically macrophages from the M1 phenotype (pro-inflammatory) to the M2 phenotype (anti-inflammatory). This led us to hypothesize that the main mechanism of anti-inflammatory effect of this molecule is linked to its immune modulation capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Fullerton, James N., and Derek W. Gilroy. 2016. Resolution of inflammation: A new therapeutic frontier. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd.2016.39.

    Article  PubMed  Google Scholar 

  2. Kotas, Maya E., and Ruslan Medzhitov. 2010. Homeostasis, inflammation, and disease susceptibility. Cell. https://doi.org/10.1016/j.cell.2015.02.010.

    Article  Google Scholar 

  3. Nathan, Carl, and Aihao Ding. 2010. Nonresolving inflammation. Cell. https://doi.org/10.1016/j.cell.2010.02.029.

    Article  PubMed  Google Scholar 

  4. Punchard, Neville A., Cliff J. Whelan, and Elan Adcock. 2004. The journal of inflammation. Journal Inflammation. https://doi.org/10.1186/1476-9255-1-1.

    Article  Google Scholar 

  5. Sugimoto, Michelle A., Lirlândia P. Sousa, Vanessa Pinho, Mauro Perretti, and Mauro M. Teixeira. 2016. Resolution of inflammation: What controls its onset? Frontiers in Immunology. https://doi.org/10.3389/fimmu.2016.00160.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nathan, Carl. 2006. Neutrophils and immunity: Challenges and opportunities. Nature Reviews Immunology. https://doi.org/10.1038/nri1785.

    Article  PubMed  Google Scholar 

  7. Lawrence, Toby, and Gilroy, Derek. W. 2007. Chronic inflammation: A failure of resolution? International Journal of Experimental Pathology. https://doi.org/10.1111/j.1365-2613.2006.00507.x.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Srivastava, M., U. Saqib, A. Naim, et al. 2017. The TLR4-NOS1-AP1 signaling axis regulates macrophage polarization. Inflammation Research 66(4):323–334. https://doi.org/10.1007/s00011-016-1017-z

  9. Cabral, G.A., and A. Staab. 2005. Effects on the immune system. In: Pertwee RG (eds) Cannabinoids. Handbook of Experimental Pharmacology. https://doi.org/10.1007/3-540-26573-2_13.

  10. Morales, P., D.P. Hurst, and P.H. Reggio. 2017. Molecular targets of the phytocannabinoids: A complex picture. Em: Kinghorn A., Falk H., Gibbons S., Kobayashi J. (eds) Phytocannabinoids. Progress in the Chemistry of Organic Natural Products. https://doi.org/10.1007/978-3-319-45541-9_4.

  11. Montecucco, Fabrizio, Fabienne Burger, Fraçois Mach, and Sabine Sttefens. 2008. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. American Journal Physiology Heart Circulatory Physiology. https://doi.org/10.1152/ajpheart.01328.2007.

    Article  Google Scholar 

  12. Xing, C., Y. Zhuang, T.H. Xu, et al. 2020. Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex. Cell 180(4):645–654.e13. https://doi.org/10.1016/j.cell.2020.01.007.

  13. Cole, J., J. Nissink, and R. Taylor. (2005). Protein-ligand docking and virtual screening with GOLD. Virtual Screening in Drug Discovery, 379–415.

  14. Jones, G., P. Willett, R.C. Glen, A.R. Leach, and R. Taylor. 1997. Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology 267 (3): 727–748. https://doi.org/10.1006/JMBI.1996.0897.

    Article  CAS  PubMed  Google Scholar 

  15. Hanwell, M.D., D.E. Curtis, D.C. Lonie, T. Vandermeerschd, E. Zurek, and G.R. Hutchison. 2012. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics 4 (8): 1–17. https://doi.org/10.1186/1758-2946-4-17/FIGURES/14.

    Article  Google Scholar 

  16. Chen, C.Y., J.S. Hu, K.Y. Xie, H. Liu, and X.M. Zhang. 2015. Investigation of condensation products of aldehydes with acetoacetic ester catalyzed by organic bases: Absolute configuration determination by X-ray crystallography and tautomeric equilibria studies by NMR spectroscopy. Research on Chemical Intermediates 41 (8): 5769–5780. https://doi.org/10.1007/S11164-014-1700-Z/TABLES/4.

    Article  CAS  Google Scholar 

  17. Neese, F. 2012. The ORCA program system. Wiley Interdisciplinary Reviews: Computational Molecular Science 2 (1): 73–78. https://doi.org/10.1002/WCMS.81/FORMAT/PDF.

    Article  CAS  Google Scholar 

  18. Neese, F. (2018). Software update: The ORCA program system, version 4.0. Wiley Interdisciplinary Reviews: Computational Molecular Science, 8(1). https://doi.org/10.1002/WCMS.1327/FORMAT/PDF.

  19. Chan, Christina, Philip Martin, Neill J. Liptrott, Marco Siccardi, Lisa Almond, and Andrew Owen. 2017. Incompatibility of chemical protein synthesis inhibitors with accurate measurement of extended protein degradation rates. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.359.

  20. Burstein, S.H., and R.B. Zurier. 2009 Cannabinoids, endocannabinoids, and related analogs in inflammation. The AAPS Journal. https://doi.org/10.1208/s12248-009-9084-5.

  21. Roberto, D., L.H. Klotz, and V. Venkateswaran. 2017. Cannabinoids as an Anticancer Agent for Prostate Cancer. Journal of Urology and Research 4(3):1090https://doi.org/10.2174/0929867322666150716115057.

  22. Berdyshev, E.V. 2000. Cannabinoid receptors and the regulation of immune response. Chemistry and Physics of Lipids. https://doi.org/10.1016/S0009-3084(00)00195-X.

  23. Samson, Maria-Teresa., Andrea Small-Howard, Lori M. N. Shimoda, Murielle Koblan-Huberson, Alexander J. Stokes, and Helen Turner. 2003. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.170.10.4953.

    Article  PubMed  Google Scholar 

  24. Small-Howard, Andrea L., Lori M. N. Shimoda, Chaker N. Adra, and Helen Turner. 2005. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. Biochemistry Journal. https://doi.org/10.1042/BJ20041682.

    Article  Google Scholar 

  25. Adan, A., Y. Kiraz, Y. Baran. 2016. Cell proliferation and cytotoxicity assays. Current Pharmacology Biotechnology. https://doi.org/10.2174/1389201017666160808160513.

  26. Hao, Ming-xiu, Li-sheng Jiang, Ning-yuan Fang, Jun Pu, Liu-hua Hu, Ling-Hong Shen, Wei Song and Ben He. 2010. The cannabinoid WIN55,212–2 protects against the inflammatory response induced by oxidized LDL in murine macrophages. Journal Lipid Research. https://doi.org/10.1194/jlr.M001511.

  27. Vannini, Federica, Khosrow Kashfi, and Niharika Nath. 2015. The dual role of iNOS in cancer. Redox Biology. https://doi.org/10.1016/j.redox.2015.08.009.

  28. Xue, Q. et al. 2018. “Regulation of iNOS on immune cells and its role in diseases”. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19123805.

  29. Mestre, Leyre, Fernando Correa, Angel Arévalo-Martín, Eduardo Molina-Holgado, Marta Valenti, Giorgio Ortar, Vincenzo Di Marzo, and Carmen Guaza. 2005. Pharmacological modulation of the endocannabinoid system in a viral modelo multiple sclerosis. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2004.02979.x.

  30. Dinarello, Charles A. 2017. Historical insights into cytokines. European Journal of Immunology. https://doi.org/10.1002/eji.200737772.

  31. Weiss, L., M. Zeira, S. Reich, M. Har-Noy, R. Mechoulam, S. Slavin, and R. Gallily. 2006. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. Research. https://doi.org/10.1080/08916930500356674.

  32. McKallip, Robert J., Catherine Lombard, Billy R. Martin, Mitzi Nagarkatti, and Prakash S. Nagarkatti. 2-2. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. Journal Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.102.033506.

  33. Brancato, S.K., and J.E. Albina. 2011. Wound macrophages as key regulators of repair: origin, phenotype, and function. The American Journal of Pathology 178(1):19–25. https://doi.org/10.1016/j.ajpath.2010.08.003.

  34. Morón-Calvente, V., S. Romero-Pinedo, S. Toribio-Castelló, J. Plaza-Díaz, A.C. Abadía-Molina, D.I. Rojas-Barros, S.T. Beug, E.C. LaCasse, A. MacKenzie, R. Korneluk, and F. Abadía-Molina. 2018. Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization. PloS One 13(3):e0193643. https://doi.org/10.1371/journal.pone.0193643.

  35. Hua, T., K. Vemuri, S.P. Nikas, R.B. Laprairie, Y. Wu, L. Qu, M. Pu, A. Korde, S. Jiang, J.H. Ho, G.W. Han, K. Ding, X. Li, H. Liu, M.A. Hanson, S. Zhao, L.M. Bohn, A. Makriyannis, R.C. Stevens, and Z.J. Liu. 2017. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547 (7664): 468–471. https://doi.org/10.1038/nature23272.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. García-Ortiz, Almudena, and Juan M. Serrador. 2017. Nitric oxide signaling in T cell-mediated immunity. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2018.02.002.

  37. Duru, Nadire, Benjamin Wolfson, and Qun Zhou. 2016. Mechanisms of the alternative activation of macrophages and non-coding RNAs in the development of radiation-induced lung fibrosis. World Journal of Biological Chemistry. https://doi.org/10.4331/wjbc.v7.i4.231.

  38. Martinez, Fernando O., Laura Helming, and Siamon Gordon. 2009. Alternative activation of macrophages: An immunological functional perspective. Annual Review of Immunology. https://doi.org/10.1146/annurev.immunol.021908.132532.

  39. Du, Y., P. Ren, Q. Wang, et al. 2018. Cannabinoid 2 receptor attenuates inflammation during skin wound healing by inhibiting M1 macrophages rather than activating M2 macrophages. Journal of Inflammation (Lond) 15:25. Published 4 Dec 2018 https://doi.org/10.1186/s12950-018-0201-z.

  40. Fitzpatric, J.K., and E.J. Downer. 2017. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis. Neuropharmacology 113(Pt B):618–626. https://doi.org/10.1016/j.neuropharm.2016.04.009.

  41. Kozela, Ewa, Maciej Pietr, Ana Juknat, Neta Rimmerman, Rivka Levy, and Zvi Vogel. 2010. Cannabinoids delta 9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-B and interferon-/STAT proinflammatory pathways in BV-2 microglial cells. The Journal of Biological Chemistry. https://doi.org/10.1074/jbc.M109.069294.

    Article  PubMed  Google Scholar 

  42. Ali, Alaa M., Osama S. El-Tawil, Asmaa K. Al-Mokaddem, Sahar S. Abd, and El-Rahman. 2021. Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2021.109398.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Dai, B., D. Wei, N.N. Zheng, et al. 2018. Coccomyxa Gloeobotrydiformis Polysaccharide Inhibits Lipopolysaccharide-Induced Inflammation in RAW 264.7 Macrophages. Cellular Physiology and Biochemistry 51(6):2523–2535. https://doi.org/10.1159/000495922.

Download references

Acknowledgements

The students (TLL, ETBM, JSR, LAE) received scholarships from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil).

Funding

This work received support from the Coordination for the Improvement of Higher Education Personnel (CAPES) and the National Council for Scientific and Technological Development (CNPq) for its development.

Author information

Authors and Affiliations

Authors

Contributions

TLL, ETBM, and JSR carried out the experimental work and performed the statistical analyses. LAE and LPS synthesized and supplied the studied molecules. EMD designed and supervised the study, helped in the statistical analysis, and corrected the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Eduardo M. Dalmarco.

Ethics declarations

Availability of Data and Materials

The data used to support the findings of this study are included in the article.

Ethics Approval and Consent to Participate

Not applicable.

Consent for Publication

All authors gave their final approval and agreement to be accountable for all aspects of the work.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lubschinski, T.L., Pollo, L.A.E., Mohr, E.T.B. et al. Effect of Aryl-Cyclohexanones and their Derivatives on Macrophage Polarization In Vitro. Inflammation 45, 1612–1630 (2022). https://doi.org/10.1007/s10753-022-01646-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-022-01646-9

KEY WORDS

Navigation